Details for 2022813008
Up to date per 04.04.2026
Actions
Details for 2022813008
Granted/Registered
European Patent
21.08.2024 A
18.02.2026 B1
15.10.2021
US
202163256432 P
A61K 9/19 20060101AFI20230503BHEP
Owner
Bioverativ Therapeutics Inc.225 Second Avenue Waltham MA 02451US
Representative
No representatives present
Inventor
CARLAGE, Tyler Waltham, Massachusetts 02451US
MAULDIN, Randall Waltham, Massachusetts 02451US
MCCOY, Timothy R. Waltham, Massachusetts 02451US
TAZI, Loubna Mzaalak Waltham, Massachusetts 02451US
Information about Fees